AJMC September 24, 2025
Pearl Steinzor, David Mitchell

David Mitchell, PharmD, MBA, senior pharmacist manager and assistant clinical professor at UC Davis, addresses how health systems are overcoming financial, operational, and access challenges for patients with rare diseases.

In part 1 of this 2-part Q&A, David Mitchell, PharmD, MBA, senior pharmacist manager and assistant clinical professor at UC Davis, discusses how health systems and specialty pharmacy teams are stepping up to ensure patients with rare diseases receive the care they need in a health care landscape where rare disease therapies are becoming increasingly complex.

From navigating insurance authorizations to identifying eligible patients and managing therapy coordination, these teams are at the forefront of breaking down barriers and advancing innovative treatments for rare diseases.

This transcript was lightly edited...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Health System / Hospital, Interview / Q&A, Pharma, Pharma / Biotech, Provider, Trends
The 250 best hospitals, according to Healthgrades
How HTM will power resilient health systems in 2026
AAMC report finds 7th consecutive year of growth in medical residents
Are Hospitals Procrastinating on TEAM Model Work?
Seeking tools for the Isle of Man

Share Article